{"id":15900,"date":"2012-11-29T19:00:00","date_gmt":"2012-11-29T18:00:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/foresti-presidente-di-teva-italia-nuovo-ad-dalla-francia\/"},"modified":"2012-11-29T19:00:00","modified_gmt":"2012-11-29T18:00:00","slug":"foresti-presidente-di-teva-italia-nuovo-ad-dalla-francia","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/foresti-presidente-di-teva-italia-nuovo-ad-dalla-francia\/","title":{"rendered":"Foresti president of Teva Italia, new CEO from France"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 14pt\">Teva has announced the appointment of <strong><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;\">Giorgio Foresti<\/span><\/strong> as president of the Italian branch of the Israeli pharmaceutical multinational. Foresti, we recall, is also the president of Assogenerici.<\/p>\n<p> At the same time, the Frenchman was appointed General Manager of Teva Italia <strong><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;\">Hubert Puech d&#039;Alissac<\/span><\/strong>. Born in 1957, Puech d&#039;Alissac was previously responsible for Europe for Teva and before that he was Senior Vice President Central &amp; Eastern Europe of Cephalon, a company acquired by Teva. In the past he had held senior positions in UCB, Sanofi-Synth\u00e9labo, Fournier and Beaufour-Ipsen.<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><span class=\"data1\"><span style=\"line-height: 115%; color: #cc0000; font-size: 10pt\">November 28, 2012 <a href=\"http:\/\/www.pharmastar.it\/index.html\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" border=\"0\" alt=\"Homepage\" style=\"width: 192px; height: 31px\" src=\"http:\/\/www.pharmastar.it\/images\/logo.jpg\" \/><\/a><\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><span class=\"data1\"><span style=\"line-height: 115%; color: #cc0000; font-size: 10pt\"><img loading=\"lazy\" decoding=\"async\" id=\"il_fi\" alt=\"\" width=\"300\" height=\"199\" style=\"padding-bottom: 8px; padding-right: 8px; padding-top: 8px\" src=\"http:\/\/www.faccphila.org\/images\/Fete10FrenchCephalon.jpg\" \/>&nbsp;<\/span><\/span><i style=\"mso-bidi-font-style: normal\"><span style=\"line-height: 115%; font-size: 9pt\"><font color=\"#000000\"><font face=\"Calibri\">Marie-Dominique de La Salle &amp; Laurence Labrid with Carole Milla &amp; <b style=\"mso-bidi-font-weight: normal\">Hubert Puech d&#039;Alissac<\/b> of Cephalon France<\/p>\n<p><\/font><\/font><\/span><\/i><\/p>","protected":false},"excerpt":{"rendered":"<p>Teva ha annunciato la nomina di Giorgio Foresti a presidente della sede italiana della multinazionale farmaceutica israeliana. Foresti, lo rammentiamo, &egrave; anche il presidente di Assogenerici. Contestualmente &egrave; stato nominato General Manager di Teva Italia il francese Hubert Puech d&rsquo;Alissac. Classe 1957, Puech d&#8217;Alissac in precedenza &egrave; stato reponsabile per l&#8217;Europa di Teva e prima &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-15900","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15900","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=15900"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15900\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=15900"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=15900"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=15900"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}